| HOME >> BIOLOGY >> TECHNOLOGY |
Other expense, net (175) (232) (533) (680)
Loss before income taxes and minority
interest (429) (1,394) (2,115) (4,691)
Minority interest in income of
subsidiary - (11) (145) (45)
Income tax benefit (provision) (3) 56 (519) (195)
Loss from continuing operations (432) (1,349) (2,779) (4,931)
Income (loss) from discontinued
operations - 496 127 (10,614)
Net loss $(432) $(853) $(2,652) $(15,545)
Net loss per common share:
Basic and diluted $(0.06) $(0.12) $(0.37) $(2.22)
Weighted-average shares used in per
share calculation:
Basic and diluted 7,213 7,031 7,171 7,004
Selected Consolidated Balance Sheet Data
August 31, November 30,
2008 2007
Cash and cash equivalents $6,328 $8,362
Accounts receivable, net 3,861 4,475
Inventory, net 1,195 1,670
Total current assets 11,942 15,164
Long-term assets 4,451 4,703
Total assets 16,393 19,867
Total current liabilities 7,885 5,620
Long-term liabilities 879 4,318
Total liabilities 8,764 9,938
Minority interest 478 407
Shareholders'
'/>"/>
| SOURCE CardioDynamics Copyright©2008 PR Newswire. All rights reserved |